2024-11-25 15:31:09
Innovent Announces First Patient Dosed in China in the Global Phase 3 Clinical Trial of Pemigatinib as the First-line Treatment of Unresectable or Metastatic Cholangiocarcinoma
Corporate/ 2023-07-23
Innovent Announces First Patient Dosed i...

SAN FRANCISCO and SUZHOU,China,May 25,2021-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical co...

Manulife makes getting physically active more rewarding in Asia
Health/ 2023-07-22
Manulife makes getting physically active...

New digital collaboration with Rewardz on the MOVE programme better incentivises customers to be physically active -- an important way to ke...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release